Catalog Number Pack Size List Price* Promo Price* Quantity
HY-10087-5MG 5 mg 62,00 46,50 Add
HY-10087-10MG 10 mg 85,00 63,80 Add
HY-10087-1ML 10 mM * 1 mL 90,00 67,50 Add
HY-10087-50MG 50 mg 221,00 165,80 Add
HY-10087-100MG 100 mg 304,00 228,00 Add
HY-10087-S-1ST Sample   Inquire

* CHF, excl. 7.7% VAT and shipping costs

Product Description

Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.

Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2 and Bcl-w, with a Ki of less than 1 nM.

Category Biochemicals
Supplier MedChem Express
Regulatory Status RUO
Research Field Cancer, Apoptosis
Format Solubility: DMF : ≥ 100 mg/mL (102.61 mM) ; DMSO : 75 mg/mL (76.95 mM; Need ultrasonic)
Grade Clinical information: Phase 2
Purity 96.09%
Molecular Formula C47H55ClF3N5O6S3
Molecular Weight 974.61
CAS-Number 923564-51-6
Storage Conditions Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
References ABT-263
Tech. Data Sheet View datasheet
Link To Supplier
Shipping Details Room temperature
Material Safety Data Sheet Download PDF